相似文献
1
Durable Polymer Drug Eluting Stent-Induced Kounis Syndrome and Eosinophilia Requiring Long-term Immunosuppression.
Can J Cardiol. 2022 Mar;38(3):398-400. doi: 10.1016/j.cjca.2021.12.001. Epub 2021 Dec 10.
2
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
JAMA Cardiol. 2017 Aug 1;2(8):855-862. doi: 10.1001/jamacardio.2017.1978.
3
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.
Lancet. 2018 Sep 1;392(10149):737-746. doi: 10.1016/S0140-6736(18)31715-X. Epub 2018 Aug 28.
4
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.
Lancet. 2014 Dec 13;384(9960):2111-22. doi: 10.1016/S0140-6736(14)61038-2. Epub 2014 Sep 1.
5
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
JACC Cardiovasc Interv. 2013 Aug;6(8):777-89. doi: 10.1016/j.jcin.2013.04.011.
6
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial.
Lancet. 2019 Oct 5;394(10205):1243-1253. doi: 10.1016/S0140-6736(19)31877-X. Epub 2019 Sep 2.
7
Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.
Lancet. 2016 Nov 26;388(10060):2607-2617. doi: 10.1016/S0140-6736(16)31920-1. Epub 2016 Oct 30.
8
Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial.
JACC Cardiovasc Interv. 2017 Feb 13;10(3):255-264. doi: 10.1016/j.jcin.2016.11.007. Epub 2017 Jan 18.
9
Kounis syndrome not induced but prevented by the implantation of a drug-eluting stent: a case report.
Anatol J Cardiol. 2017 May;17(5):412-413. doi: 10.14744/AnatolJCardiol.2017.7690.
10
Very Late Stent Thrombosis: The Value of Optical Coherence Tomography in Defining Etiology and Guiding Treatment.
Can J Cardiol. 2016 Jun;32(6):830.e9-830.e10. doi: 10.1016/j.cjca.2015.08.008. Epub 2015 Aug 15.
引用本文的文献
1
Kounis Syndrome: Review of Clinical Cases.
Cardiovasc Hematol Disord Drug Targets. 2024;24(2):83-97. doi: 10.2174/011871529X305833240708051508.
2
Stentless percutaneous coronary intervention with directional coronary atherectomy and drug-coated balloon angioplasty in worsening angina patients with metal allergies.
J Cardiol Cases. 2022 Oct 13;27(1):32-35. doi: 10.1016/j.jccase.2022.09.014. eCollection 2023 Jan.
本文引用的文献
1
Evidence-Based Practices in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association.
Circulation. 2021 Aug 3;144(5):e107-e119. doi: 10.1161/CIR.0000000000000996. Epub 2021 Jun 30.
2
North American Contact Dermatitis Group Patch Test Results: 2015-2016.
Dermatitis. 2018 Nov/Dec;29(6):297-309. doi: 10.1097/DER.0000000000000417.
3
Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management.
Clin Chem Lab Med. 2016 Oct 1;54(10):1545-59. doi: 10.1515/cclm-2016-0010.
4
Thrombotic complications associated with transcatheter aortic valve implantation: the role of Kounis hypersensitivity-associated thrombotic syndrome.
Cardiovasc Pathol. 2014 Nov-Dec;23(6):383-4. doi: 10.1016/j.carpath.2014.06.004. Epub 2014 Jun 21.
5
Development of a novel biocompatible polymer system for extended drug release in a next-generation drug-eluting stent.
J Biomed Mater Res A. 2008 Jun 15;85(4):1064-71. doi: 10.1002/jbm.a.31664.
Zotero 插件